Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.

Abstract:

:A double-blind, crossover trial was carried out in 40 in-patients with gastro-intestinal spasmodic syndromes to compare the effectiveness and tolerance of fenoverine and trimebutine. Patients were allocated at random to receive either 100 mg fenoverine or 150 mg trimebutine 3-times daily for 20 days and were then crossed over, without a wash-out period, to the alternative medication for a further 20 days. After the first dose, pain severity was monitored over 4 hours and changes in intensity compared between groups. During the two 20-day periods, the proportion of patients in complete or almost complete remission was monitored at 10-day intervals, and the pooled data similarly compared. At the end of the 40-day trial period, patients stated their preference for one or other treatment, and the relevant data were processed by sequential analysis. Subjective signs of adverse effects were monitored by questioning every 10 days, and haematology and haematochemistry before and after each phase of the study. The results showed that fenoverine produced significantly greater pain relief after a single dose in comparison with trimebutine over the 4 hours of observation. Similarly, it gave significantly more favourable clinical results after both the 10th and 20th day of treatment. Finally, according to the patients' preference, fenoverine was significantly preferred (p less than 0.05) in comparison with trimebutine. Neither treatment was associated with the onset of signs of possible adverse reactions, either subjective or objective.

journal_name

Curr Med Res Opin

authors

Camarri E

doi

10.1185/03007998609111090

subject

Has Abstract

pub_date

1986-01-01 00:00:00

pages

52-7

issue

1

eissn

0300-7995

issn

1473-4877

journal_volume

10

pub_type

临床试验,杂志文章,随机对照试验
  • Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.

    abstract::A double-blind, randomized study was carried out in 43 women, who had undergone spontaneous menopause at least 6 months earlier, to compare the effectiveness and tolerance of veralipride with that of a conjugated oestrogens preparation in the control of hot flushes. Twenty-one women received 100 mg veralipride per day...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998409110119

    authors: Wesel S,Bourguignon RP,Bosuma WB

    更新日期:1984-01-01 00:00:00

  • Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation.

    abstract::Aims: We sought to investigate the reasons for, and rates of, novel oral anticoagulant (DOAC) therapy discontinuation.Methods: This was an observational cohort study of patients with atrial fibrillation (AF) referred to a regional DOAC outpatient clinic between February 2013 and October 2017. The study population cons...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1725743

    authors: Mitrovic D,Folkeringa R,Veeger N,van Roon E

    更新日期:2020-04-01 00:00:00

  • A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.

    abstract:BACKGROUND:Basal cell carcinoma (BCC) is the most common cancer. Most cases of BCCs are treated with only optimal surgical resection. However, unresectable, locally advanced or metastatic tumors might have potential to progress. In this patient group, there is no standardized treatment approach. Vismodegib is a new sel...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1018988

    authors: Erdem GU,Sendur MA,Ozdemir NY,Yazıcı O,Zengin N

    更新日期:2015-04-01 00:00:00

  • Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.

    abstract:OBJECTIVE:Decision aids (DAs) are increasingly used to operationalize shared decision-making (SDM) but their development is not often described. Decisions about oral anticoagulants (OACs) for atrial fibrillation (AF) involve a trade-off between lowering stroke risk and increasing OAC-associated bleeding risk, and consi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1096767

    authors: Kaiser K,Cheng WY,Jensen S,Clayman ML,Thappa A,Schwiep F,Chawla A,Goldberger JJ,Col N,Schein J

    更新日期:2015-12-01 00:00:00

  • The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients.

    abstract:BACKGROUND:The goals of diabetes management have evolved over the past decade to become the attainment of near-normal glucose and cardiovascular risk factor levels. Improved metabolic control is achieved through optimized medication regimens, but costs specifically associated with such optimization have not been examin...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X132523

    authors: Crivera C,Suh DC,Huang ES,Cagliero E,Grant RW,Vo L,Shin HC,Meigs JB

    更新日期:2006-11-01 00:00:00

  • Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.

    abstract:OBJECTIVE:This trial evaluated the efficacy and safety of pregabalin dosed twice daily (BID) for relief of neuro-pathic pain associated with postherpetic neuralgia (PHN). RESEARCH DESIGN AND METHODS:The 13-week, double-blind, placebo-controlled study randomized 370 patients with PHN to pregabalin (150, 300, or 600 mg/...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906x80404

    authors: van Seventer R,Feister HA,Young JP Jr,Stoker M,Versavel M,Rigaudy L

    更新日期:2006-02-01 00:00:00

  • Extended adjuvant endocrine therapy of early breast cancer.

    abstract::Women who are diagnosed with early breast cancer remain at considerable risk of recurrence over the next several decades, even if their tumors were small and lymph nodes were negative, and despite receiving standard adjuvant therapy. A majority of breast cancers are hormone (estrogen) receptor-positive and amenable to...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079905X65619

    authors: Chowdhury S,Ellis P

    更新日期:2005-12-01 00:00:00

  • Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

    abstract:BACKGROUND:Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes (T2DM), reduced hemoglobin A(1c) (A1C) and weight in clinical trials. The objective of this study was to evaluate the effects of > or = 3 years exenatide therapy on glycemic control, body weight, cardiometabolic markers, and safety. ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079908x253870

    authors: Klonoff DC,Buse JB,Nielsen LL,Guan X,Bowlus CL,Holcombe JH,Wintle ME,Maggs DG

    更新日期:2008-01-01 00:00:00

  • Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy.

    abstract:BACKGROUND:The selection of the most appropriate treatment combinations requires the balancing of benefits and harms of these treatment options as well as the patients' preferences for the resulting outcomes. OBJECTIVE:This research aimed at estimating and comparing the utility weights between elderly women with early...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1257983

    authors: Ali AA,Xiao H,Tawk R,Campbell E,Semykina A,Montero AJ,Diaby V

    更新日期:2017-02-01 00:00:00

  • A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.

    abstract:BACKGROUND:Natalizumab is a highly effective treatment for patients with relapsing-remitting multiple sclerosis (RRMS). Treatment with natalizumab has been associated with progressive multifocal leukoencephalopathy (PML), a rare yet serious disease of the brain. Published studies have quantified the PML risk by the pre...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.869492

    authors: Walker A,Watson C,Alexopoulos ST,Deniz B,Arnold R,Bates D

    更新日期:2014-04-01 00:00:00

  • Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets.

    abstract:OBJECTIVE:To compare real-world adherence to and persistence with deferasirox film-coated tablets (DFX-FCT) and deferasirox dispersible tablets (DFX-DT) among patients who switched from DFX-DT to DFX-FCT, overall and by disease type (sickle cell disease [SCD], thalassemia, and myelodysplastic syndrome [MDS]). METHODS:...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1470500

    authors: Cheng WY,Said Q,Hao Y,Xiao Y,Vekeman F,Bobbili P,Duh MS,Nandal S,Blinder M

    更新日期:2018-11-01 00:00:00

  • Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.

    abstract:BACKGROUND:In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD). AIM:To examine symptom relief during week 1 of rabeprazole therapy, in addition to GORD healing, in a clinical practice setting. METHODS:In this...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/030079905X41444

    authors: Archimandritis AJ,Nikolopoulou V,Kouklakis G,Paraskevas E,Avgerinos A,Tsianos E,Triantafillidis JK,Hellenic Rabeprazole Study Group.

    更新日期:2005-04-01 00:00:00

  • Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis.

    abstract:OBJECTIVE:This meta-analysis compared the median overall survival (mOS) of brentuximab vedotin reported in the pivotal phase 2 study with published results of other therapies for the treatment of relapsed/refractory (R/R) Hodgkin lymphoma (HL) post autologous stem cell transplant (ASCT). RESEARCH DESIGN AND METHODS:A ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/03007995.2015.1048208

    authors: Bonthapally V,Yang H,Ayyagari R,Tan RD,Cai S,Wu E,Gautam A,Chi A,Huebner D

    更新日期:2015-01-01 00:00:00

  • Focus on olanzapine.

    abstract::Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine) is a novel antipsychotic agent of the theinobenzodiazepine class developed by Eli Lilly & Co. It has a pleotrophic pharmacology and affects the dopaminergic, serotonergic, muscarinic and adrenergic systems. The therapeutic advantage...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007999909113367

    authors: Green B

    更新日期:1999-01-01 00:00:00

  • Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.

    abstract:BACKGROUND:Studies have shown that many patients with type 2 diabetes do not achieve optimal glycemic control, and progression of diabetes over time requires more than one pharmacotherapy to achieve glycemic goal. OBJECTIVE:To examine the efficacy and safety of the fixed-dose combination (FDC) of pioglitazone 15 mg an...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007990903350011

    authors: Perez A,Zhao Z,Jacks R,Spanheimer R

    更新日期:2009-12-01 00:00:00

  • The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication.

    abstract:OBJECTIVES:Cardiovascular disease (CVD) is the leading cause of mortality worldwide. A high level of low-density lipoprotein cholesterol (LDL-C) is a major CVD risk factor. Guidelines recommend effective cholesterol management and set LDL-C goals, yet deficiencies exist in physician implementation of these recommendati...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079908x280491

    authors: Hobbs FD,Erhardt LR,Rycroft C,Heart study investigators.

    更新日期:2008-05-01 00:00:00

  • Effects of long-term ergoloid mesylates ('Hydergine') administration in healthy pensioners: 5-year results.

    abstract::Five-year results are reported of a controlled long-term comparative study to assess the effects of ergoloid mesylates (1.5 mg 3-times daily) and placebo on medical, psychological and electrophysiological variables. Initially, 148 healthy elderly volunteers of both sexes were included. Eighty-nine subjects (48 on ergo...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007998609110447

    authors: Huber F,Köberle S,Prestele H,Spiegel R

    更新日期:1986-01-01 00:00:00

  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.

    abstract:OBJECTIVE:To compare glycemic goal achievement (HbA(1c) < 7%) in type 2 diabetes patients receiving initial metformin plus pioglitazone combination therapy and initial metformin monotherapy augmented with pioglitazone in a cohort follow-up study. RESEARCH DESIGN AND METHODS:Adult patients were identified from the Inge...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.536755

    authors: Pandya BJ,Bron M,McCall T,Yu AP,Chen KS,Mattson ME,Wu EQ

    更新日期:2011-01-01 00:00:00

  • Association between asthma/chronic obstructive pulmonary disease overlap syndrome and healthcare utilization among the US adult population.

    abstract::Objectives: Asthma/chronic obstructive pulmonary disease (COPD) overlap (ACO) is a recently described phenomenon defined as the coexistence of both asthma and COPD. Both asthma and COPD are known to result in increased emergency department (ED) visits and hospitalizations, but it is unclear how the ACO population util...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2019.1565531

    authors: Kim M,Tillis W,Patel P,Davis RM,Asche CV

    更新日期:2019-07-01 00:00:00

  • Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries.

    abstract:OBJECTIVE:To evaluate knowledge about risks, prevention and consequences of infection with hepatitis B virus (HBV) among travellers from four low HBV risk, European countries. METHODS:Individuals from an internet panel and based in the Czech Republic, the Netherlands, Spain and Sweden were invited to take part in an o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.546392

    authors: Herbinger KH,Nothdurft HD,Prymula R

    更新日期:2011-03-01 00:00:00

  • A proposal for the organization of the referral of patients with chronicnon-specific low back pain.

    abstract:BACKGROUND:Low back pain in general and specifically chronic low back pain forms a major burden for the patient and society. Recently studies demonstrated that up to 65% of patients evolve to chronic pain as opposed to the previously accepted 8%. As low back pain patients present first with their general practitioner, ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1220933

    authors: Itz C,Huygen F,Kleef MV

    更新日期:2016-11-01 00:00:00

  • Single daily dose treatment of anxiety with clobazam: a double-blind study versus normal multiple-dose treatment with diazepam.

    abstract::A double-blind trial was carried out in 45 anxious out-patients to compare the effectiveness and tolerance of clobazam and diazepam. The severity of each patient's symptoms was assessed before, during and at the end of the trial period using the Hamilton Anxiety Rating Scale, and a note kept of any side-effects. The r...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998009109494

    authors: Botter PA

    更新日期:1980-01-01 00:00:00

  • Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.

    abstract:OBJECTIVE:To compare clinical characteristics, statin treatment patterns and adherence among patients at different risk for coronary heart disease (CHD) as defined by National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines. METHODS:Patients ≥ 18 years old with ≥ 1 claim for dyslipidemi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.971151

    authors: Kern DM,Balu S,Tunceli O,Anzalone D

    更新日期:2014-12-01 00:00:00

  • Effect of prophylactic bisoprolol plus magnesium on the incidence of atrial fibrillation after coronary bypass surgery: results of a randomized controlled trial.

    abstract:OBJECTIVE:Bisoprolol, a highly cardioselective beta(1)-blocker, is widely used to treat elderly patients with hypertension, coronary artery disease and heart failure. The current literature lacks evidence regarding its potency to prevent atrial fibrillation (AF) following cardiac surgery. Therefore the aim of this stud...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X115649

    authors: Behmanesh S,Tossios P,Homedan H,Hekmat K,Hellmich M,Müller-Ehmsen J,Schwinger RH,Mehlhorn U

    更新日期:2006-08-01 00:00:00

  • Tranexamic acid in gynecologic surgery.

    abstract::Objective: To review the mechanism of action, pharmacology, dosing, and complications of tranexamic acid (TXA) and consolidate current evidence for TXA in gynecologic surgery.Methods: A literature search of PubMed, Ovid (MEDLINE), Google Scholar, and Elsevier was performed, in addition to a targeted search of cited re...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2019.1708533

    authors: Zakhari A,Sanders AP,Solnik MJ

    更新日期:2020-03-01 00:00:00

  • Good publication practice guidelines for medical communications agencies: a MedComm perspective.

    abstract:BACKGROUND:Physicians and other health care personnel rely on the peer-reviewed biomedical literature as a key source for making clinical decisions. Thus, ensuring that the nonclinical and clinical findings published in biomedical journals are reported accurately and clearly, without undue influence from commercial int...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802646584

    authors: Bareket-Samish A,Denny M,Ruzicka B,Bogush M,Flynn K,Glinka K,McMahon-Wise B,Schiller S,Sjostedt P,Matheson N

    更新日期:2009-02-01 00:00:00

  • Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.

    abstract:OBJECTIVE:Osteoarthritis is one of the most common forms of arthritis seen in primary care. Non-steroidal anti-inflammatory drugs (NSAIDs) play an important role in the management of osteoarthritis. However, gastrointestinal (GI) side effects limit their use. Cyclooxygenase-2 (COX-2) selective inhibitors exhibit better...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X104722

    authors: Pareek A,Chandanwale AS,Oak J,Jain UK,Kapoor S

    更新日期:2006-05-01 00:00:00

  • An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis.

    abstract::A trial to compare the therapeutic potential of 1200 mg. azapropazone daily with 3.9 g. aspirin daily was carried out in 108 out-patients with rheumatoid arthritis over a 14-day period. Analysis of results from the 85 patients with completed assessment data (49 on azapropazone; 36 on aspirin) showed that azapropazone ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007997609109281

    authors: Brooks PM,Mason DI,McNeil R,Anderson JA,Buchanan WW

    更新日期:1976-01-01 00:00:00

  • Daily fluctuations in the plasma cortisol level of children with rheumatoid arthritis before and after treatment with tetracosactrin ('Cortrosyn Depot') and corticosteroid hormones.

    abstract::Daily fluctuations in plasma cortisol levels were studied in three groups of children with rheumatoid arthritis. One group was untreated with hormones, the second treated with a depot preparation of tetracosactrin, and the third group with corticosteroid hormones. The results obtained were compared with the rhythm in ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007997709109336

    authors: Tsvetkova V

    更新日期:1977-01-01 00:00:00

  • Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs.

    abstract:BACKGROUND:Low-dose acetylsalicylic acid (ASA; aspirin; 75-325 mg/day) is effective for the prevention of cardiovascular events, and its use in this indication is rapidly increasing. However, the use of ASA and, indeed, other non-steroidal anti-inflammatory drugs (NSAIDs) is limited by the incidence of adverse gastrodu...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903212682

    authors: Yeomans ND,Hawkey CJ,Brailsford W,Naesdal J

    更新日期:2009-11-01 00:00:00